The Threat of Biological Weapons Must Be Addressed

Editor's Note: Joshua Lederberg, chairman of The Scientist's Editorial Advisory Board, edited the book Biological Weapons: Limiting the Threat, to be published this spring (May 1999) by The MIT Press. The following article, adapted from the book's epilogue, is printed with permission of The MIT Press. As the works for Biological Weapons: Limiting the Threat were being assembled, our policy perspectives were informed by new happenings and governmental reactions. Saddam Hussein renewed his h

Written byJoshua Lederberg
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Editor's Note: Joshua Lederberg, chairman of The Scientist's Editorial Advisory Board, edited the book Biological Weapons: Limiting the Threat, to be published this spring (May 1999) by The MIT Press. The following article, adapted from the book's epilogue, is printed with permission of The MIT Press.

As the works for Biological Weapons: Limiting the Threat were being assembled, our policy perspectives were informed by new happenings and governmental reactions. Saddam Hussein renewed his harassment of the United Nations inspectors seeking closure on Iraq's programs in biological weapons and other weapons of mass destruction. For the nth time, final rupture seemed imminent, and with it the threat of U.S. cruise missile attacks on relevant Iraqi facilities. That escalation might be a deterrent/warning, or it might provoke unreasoned responses, including the use of biological weapons if the regime inferred it had nothing more to lose.

The dilemma persists how to invoke punishment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies